Personal Genome Diagnostics, backed by nearly $25 million in venture funding, has named a new CEO.
The Baltimore genome sequencing company tapped Douglas Ward to lead the company. He will also become a member of the board.
Ward joins Personal Genome from Roche, where he was vice president of companion diagnostics for Ventana Medical Systems Inc.
Read more at Baltimore Business Journal
The post Personal Genome Diagnostics names new CEO appeared first on Baltimore Tech.
from http://baltimoretech.org/news/personal-genome-diagnostics-names-new-ceo/
No comments:
Post a Comment